Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
18.4 USD | -0.86% | +6.71% | +64.07% |
May. 15 | B. Riley Raises Price Target on Harrow Health to $29 From $26, Keeps Buy Rating | MT |
May. 14 | Transcript : Harrow, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+64.07% | 657M | |
+38.16% | 727B | |
+30.73% | 592B | |
-7.54% | 347B | |
+15.60% | 319B | |
+0.73% | 274B | |
+12.25% | 238B | |
+6.87% | 204B | |
-5.77% | 203B | |
-3.04% | 160B |
- Stock Market
- Equities
- HROW Stock
- News Harrow, Inc.
- B. Riley Raises Harrow Health's Price Target to $20 from $17 After Higher-than-Expected Q1 Revenue, Keeps Buy Rating